Mangrove Partners’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Hold |
2,525,252
| – | – | 0.39% | 43 |
|
|
2025
Q1 | $3.28M | Hold |
2,525,252
| – | – | 0.35% | 49 |
|
|
2024
Q4 | $3.64M | Buy |
+2,525,252
| New | +$3.64M | 0.4% | 49 |
|
|
2023
Q4 | – | Sell |
-399,219
| Closed | -$1.22M | – | 176 |
|
|
2023
Q3 | $1.22M | Hold |
399,219
| – | – | 0.09% | 120 |
|
|
2023
Q2 | $938K | Hold |
399,219
| – | – | 0.07% | 160 |
|
|
2023
Q1 | $1.16M | Hold |
399,219
| – | – | 0.08% | 176 |
|
|
2022
Q4 | $968K | Hold |
399,219
| – | – | 0.05% | 249 |
|
|
2022
Q3 | $1.12M | Hold |
399,219
| – | – | 0.06% | 256 |
|
|
2022
Q2 | $2.08M | Hold |
399,219
| – | – | 0.1% | 291 |
|
|
2022
Q1 | $2.83M | Sell |
399,219
-7,840
| -2% | -$55.5K | 0.15% | 230 |
|
|
2021
Q4 | $2.5M | Sell |
407,059
-9,487
| -2% | -$58.3K | 0.15% | 212 |
|
|
2021
Q3 | $2.73M | Sell |
416,546
-11,954
| -3% | -$78.3K | 0.24% | 134 |
|
|
2021
Q2 | $2.92M | Buy |
+428,500
| New | +$2.92M | 0.3% | 74 |
|